Literature DB >> 11246848

A prospective cohort study of physical activity and body size in relation to prostate cancer risk (United States).

I M Lee1, H D Sesso, R S Paffenbarger.   

Abstract

OBJECTIVES: To examine the associations of physical activity and body size with risk of prostate cancer.
METHODS: At baseline in 1988, 8922 men (mean age 67 years) completed a health questionnaire which included information on physical activity, body weight, and waist girth. In a subgroup (74% of men), physical activity data also had been provided in 1962 or 1966 and again in 1977. Additionally, body weight measured at age 18 was available for 92% of men. During follow-up from 1988 through 1993, 439 men developed prostate cancer.
RESULTS: In multivariate analyses that accounted for potential confounders, the RRs (95% CI) for < 4200, 4200-8399, 8400-12,599, and > or = 12,600 kJ/week of physical activity at baseline were 1.00 (referent), 1.13 (0.84-1.52), 0.96 (0.68-1.35), and 1.04 (0.79-1.38), respectively. For body mass indexes (BMI) of < 22.5, 22.5-24.9, 25.0-27.4, and > or = 27.5 kg/m2 at baseline, corresponding results were 1.00 (referent), 1.27 (0.94-1.71), 1.26 (0.92-1.72), and 1.02 (0.68-1.53), respectively. For waist girths of < or = 86.4, 86.5-91.4, 91.5-96.5, and > 96.5 cm, they were 1.00 (referent), 1.30 (0.96-1.76), 1.31 (0.96-1.80), and 1.19 (0.85-1.65), respectively. Combining physical activity measures from the past, or examining vigorous activities only, did not yield any significant associations. BMI at age 18 also was not related to risk.
CONCLUSION: These findings do not support a role of physical activity or body weight in prostate cancer etiology.

Entities:  

Mesh:

Year:  2001        PMID: 11246848     DOI: 10.1023/a:1008952528771

Source DB:  PubMed          Journal:  Cancer Causes Control        ISSN: 0957-5243            Impact factor:   2.506


  23 in total

Review 1.  Potential for prostate cancer prevention through physical activity.

Authors:  Stacey Young-McCaughan
Journal:  World J Urol       Date:  2011-12-24       Impact factor: 4.226

2.  Physical activity and body mass index as predictors of prostate cancer risk.

Authors:  Alessandra Grotta; Matteo Bottai; Hans-Olov Adami; Swann Arp Adams; Olof Akre; Steven Noel Blair; Daniela Mariosa; Olof Nyrén; Weimin Ye; Pär Stattin; Rino Bellocco; Ylva Trolle Lagerros
Journal:  World J Urol       Date:  2015-01-04       Impact factor: 4.226

Review 3.  [Epidemiological evidence for preventing prostate cancer by physical activity].

Authors:  Hans-Christian Heitkamp; Ivan Jelas
Journal:  Wien Med Wochenschr       Date:  2012-10-12

4.  Occupational risk factors for prostate cancer and benign prostatic hyperplasia: a case-control study in Western Australia.

Authors:  L Fritschi; D C Glass; J S Tabrizi; J E Leavy; G L Ambrosini
Journal:  Occup Environ Med       Date:  2006-10-03       Impact factor: 4.402

Review 5.  Physical Activity and Prostate Cancer: An Updated Review.

Authors:  Roy J Shephard
Journal:  Sports Med       Date:  2017-06       Impact factor: 11.136

Review 6.  The Relationship Between Physical Activity and Risk of Atrial Fibrillation-A Systematic Review and Meta-Analysis.

Authors:  Jens Rokkedal Nielsen; Kristian Wachtell; Jawdat Abdulla
Journal:  J Atr Fibrillation       Date:  2013-02-12

7.  Examining the relationship between obesity and prostate cancer.

Authors:  Stephen J Freedland; William J Aronson
Journal:  Rev Urol       Date:  2004

8.  Cardiorespiratory fitness and risk of prostate cancer: findings from the Aerobics Center Longitudinal Study.

Authors:  Wonwoo Byun; Xuemei Sui; James R Hébert; Timothy S Church; I-Min Lee; Charles E Matthews; Steven N Blair
Journal:  Cancer Epidemiol       Date:  2010-08-13       Impact factor: 2.984

9.  Exercise in cancer.

Authors:  P Rajarajeswaran; R Vishnupriya
Journal:  Indian J Med Paediatr Oncol       Date:  2009-04

10.  Body mass index and cancer incidence: the FINRISK study.

Authors:  Xin Song; Eero Pukkala; Tadeusz Dyba; Jaakko Tuomilehto; Vladislav Moltchanov; Satu Männistö; Pekka Jousilahti; Qing Qiao
Journal:  Eur J Epidemiol       Date:  2014-07-06       Impact factor: 8.082

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.